Universal-Beteiligungs- und Servicegesellschaft’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.59M Buy
22,822
+1,736
+8% +$197K ﹤0.01% 1089
2025
Q1
$2.22M Buy
+21,086
New +$2.22M ﹤0.01% 1126